Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance.
about
Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1Nutrient-driven incretin secretion into intestinal lymph is different between diabetic Goto-Kakizaki rats and Wistar ratscDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effectsHuman duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.The role of incretins in glucose homeostasis and diabetes treatment.Metabolic surgery and intestinal gene expression: Digestive tract and diabetes evolution considerations.The role of incretin therapy at different stages of diabetes.Physiology of weight loss surgery.Contribution of nonesterified fatty acids to insulin resistance in the elderly with normal fasting but diabetic 2-hour postchallenge plasma glucose levels: the Baltimore Longitudinal Study of AgingUbiquitination is involved in glucose-mediated downregulation of GIP receptors in islets.High prevalence of cardiometabolic risk factors in Hispanic adolescents: correlations with adipocytokines and markers of inflammation.GIP and bariatric surgery.Glucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesity-associated disorders.Modeling the oral glucose tolerance test in normal and impaired glucose tolerant states: a population approach.Postmeal increment in intact glucagon-like peptide 1 level, but not intact glucose-dependent insulinotropic polypeptide levels, is inversely associated with metabolic syndrome in patients with type 2 diabetes.Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
P2860
Q24682766-E361D9E7-21CA-4E11-85C0-2A72445D366AQ28564632-5B6E4364-0303-4EC2-AA31-21B5171B500FQ28574297-312A8C07-6BE6-476E-9B68-991C1474AD29Q33225025-1A1AD1C3-6CA8-476C-8ACB-72AC09A1467CQ34901533-C1FB6E30-78F7-4E8D-B6FF-BDE335C7BAC2Q35716332-38D47F1A-E432-49B9-AD0F-A6B246D9A2CEQ35760288-CEEF5F3E-A90C-4700-B3FB-0DA8006924FBQ36055375-EDFE5B66-0BE4-449F-BF88-1E990F385776Q36157051-3CBEF059-BE06-45B6-9A40-1E58B46C979CQ37093181-0BADFBD2-3618-4A16-ACD2-A431F3A297E2Q37445924-F5C4E2C1-E280-4C68-942E-7922122B164FQ37809995-6D4CCEB9-4179-45BA-91BA-E69E240B9701Q37911549-779E7BA6-9C19-45A4-BC9E-093D4F6CAB92Q39235496-37224431-8FF4-4997-9049-407344E28188Q48190264-3EBF61CE-2E71-43BE-84E2-C87A1A2EA54AQ51344862-BDC5E6CB-F838-4BF9-9C9A-DC578505B915
P2860
Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Elevated plasma glucose-depend ...... in impaired glucose tolerance.
@en
Elevated plasma glucose-depend ...... in impaired glucose tolerance.
@nl
type
label
Elevated plasma glucose-depend ...... in impaired glucose tolerance.
@en
Elevated plasma glucose-depend ...... in impaired glucose tolerance.
@nl
prefLabel
Elevated plasma glucose-depend ...... in impaired glucose tolerance.
@en
Elevated plasma glucose-depend ...... in impaired glucose tolerance.
@nl
P2093
P1433
P1476
Elevated plasma glucose-depend ...... in impaired glucose tolerance.
@en
P2093
Denis C Muller
Michael J Theodorakis
Olga Carlson
P304
P356
10.2337/DIACARE.27.7.1692
P407
P577
2004-07-01T00:00:00Z